SAN FRANCISCO, May 20, 2025 /PRNewswire/ — Trial Library, a technology company focused on equitable access to oncology clinical trials, announced its collaboration with Texas Oncology, one of the largest and most respected cancer care practices in the United States. This collaboration will leverage Trial Library’s innovative patient navigation platform to streamline clinical trial access for patients at Texas Oncology.
“Cancer treatment often presents significant challenges, including care coordination, socioeconomic hurdles, and logistical complexities. We hope that Trial Library will improve patient access to vital clinical trial resources.” Dr. Scott Paulson, Research Medical Director, Texas Oncology.
Trial Library’s platform is designed to alleviate these obstacles by connecting patients with tailored support, empowering them to make informed decisions, and ensuring equitable access to vital care resources. Through this relationship, Trial Library’s platform will be seamlessly integrated into Texas Oncology’s operations, offering personalized navigation to patients referred to clinical trials.
“By working with Texas Oncology, we’re advancing our mission to provide patients with streamlined access to clinical trials,” said Dr. Hala Borno, CEO and Founder of Trial Library. “Our technology simplifies clinical trial navigation and enhances the connection between patients and trial sites.”
About Trial Library
Trial Library is the leading AI-powered solution for recruitment and retention, trusted by oncologists across the United States. Learn more at www.triallibrary.com.
Media Contact:
info@triallibrary.com
SOURCE Trial Library, Inc
Telehealth Provider Offers FDA-Approved and Compounded Weight Loss Medications in All 50 States, Subject to…
Telehealth Platform Facilitates Compounded Semaglutide and Tirzepatide Access Through Licensed Provider Evaluation as FDA Shortage…
Analysis examines best peptides for boosting growth hormone as ReadyRx lists prescription sermorelin in injectable…
Discover the best fat burner for men in 2025. Explore Wolfson Brand’s effective fat-burning supplements…
Industry Analysis Examines How Cost, Safety, and Access Considerations Shape Semaglutide Choices as MEDVi Lists…
Deploying “Proof of Human” Infrastructure throughout Japan, a Technology Envisioned by Sam Altman and Alex…